Sentences with phrase «than dividend increases»

It is important to know with a variable loan interest rate, loan rates go up faster than dividend increases, you could easily find yourself on the wrong side of the curve.

It is important to know with a variable loan interest rate, loan rates go up faster than dividend increases, you could easily find yourself on the wrong side of the curve.

And while they are a more subtle way of sharing a company's economic prosperity with its stakeholders than a dividend increase, buybacks can profit investors too.

What matters more than a dividend increase or reduction is the capital gain you can capture or loss you avoid up to 1 - year before the announcement is made.

Not exact matches

This Toronto - based property and casualty insurance company has increased its dividend by more than 50 % over the past three years while its stock price has climbed from $ 35 to $ 62.

You can think of the «return» on this investment as the value of paying yourself, rather than a landlord, even if it's not paying dividends or increasing in value.

While some banks, such as Wells Fargo, are paying more per share than they were before the recession, others, like Citigroup, haven't increased dividends at all.

The tax cut and excess federal spending may boost some areas of the economy, but thus far, it has not produced anything more than a modest boost in capital spending (most of it from capital intensive technology companies) but a surge in stock buybacks and dividend increases, Apple being a case in point.

April 23 (Reuters)- Barrick Gold Corp reported a slightly better than expected increase in first - quarter adjusted profit on Monday and said it was done selling assets to cut debt and would instead use funds from any future sales to boost growth or pay dividends.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Companies in the S&P 500 are on track to give investors more than $ 1 trillion in stock buybacks and dividend increases this year, according to Howard Silverblatt, a senior analyst at S&P Dow...

Companies with records of steadily increasing dividends usually fared better in the ratings than those in which dividend growth has been erratic or where dividend cuts or omissions have occurred.

Dividend Growth Investing is an income strategy of investing in companies that have a barrier to entry (large moat) and consistent history of increasing dividends by a rate higher than inflation.

Is there anything sweeter than opening up your laptop after a hard day's work, checking your dividend portfolio, and then realizing that one of your holdings increased their dividend that day?

Spending on commissions by its $ 21 billion Equity Dividend Fund increased by 39 percent from the 2014 to 2016 fiscal years, but the fund's transaction activity more than doubled, meaning that its commission rate overall decreased considerably.

In April 2013, the board authorized a dramatic increase, more than doubling the size of the program to $ 100 billion, raising the dividend, and increasing the share buyback authorization to $ 60 billion.

Unilever posted better - than - expected first quarter revenues and increased its quarterly dividend by 12 % as it continues to appease shareholders after a failed takeover attempt by Kraft Heinz.

In my experience, a dividend growth portfolio strategy seems to be performing better as an investment than owning a home, in my honest opinion, I would rather rent in a great area than own a home in that area, jeez if I were able to get a lease agreement for 10 years indexed at inflation or at 2.5 % increase annually I would take it and take my down payment and invest it in my portfolio, and continue to contribute the max in my 401K, HSA, and Roth IRA, while enjoying living in a low tax bracket because of my contributions.

Although it «s only a rather small dividend increase, I «m more than happy about it.

higher annual dividend increase (3 - 4 % annual increase vs 1 - 1.8 % for canadian reit) and a lower payout ratio than canadian reit.

A value over 1.0 suggests that the dividend growth rate has been increasing as the 5 year rate is higher than the 10 year rate.

higher annual dividend increase (3 - 4 % annual increase vs 1.1.8 for canadian reit) and a lower payout ratio than canadian reit.

«GCG switched from an annual dividend of $ 0.20 to quarterly dividends of $ 0.05 in 2013 so dividends in 2013 were $ 0.30 ($ 0.20 + 0.05 + 0.05) which was higher than 2014, but quarterly dividends where increased in 2014 so the dividend streak was maintained.»

In April 2013, the Board authorized a dramatic increase, more than doubling the size of the program to $ 100 billion, raising the dividend, and increasing the share buyback authorization to $ 60 billion.

That time frame, more than two decades long, actually includes many periods of extreme volatility in commodity pricing, yet Enbridge kept right on paying and increasing its dividend.

In addition, Prudential has regularly increased its dividend over the past decade, and its current yield of just over 3.4 % has been achieved despite paying out less than 20 % of its earnings as dividends.

These positive earnings drivers were more than offset by the combined impact of several factors, including increased energy - related provisions for credit losses, a 17 basis point decline in net interest margin, moderate growth of non-interest expenses, the addition of acquisition - related contingent consideration fair value changes reflecting performance within CWB Maxium Financial (CWB Maxium), higher preferred share dividends, and the 20 % increase to CWB's income tax rate in Alberta.

The trend has been for companies to use retained earnings to buy back shares rather than increase their dividend payouts.

At 44.4 %, however, less than half of the company's earnings are being returned to shareholders via a dividend, providing plenty of room for more increases going forward.

A third benefit is that compound interest is more likely to work with you rather than against you, through the compounding of increased dividends and retained earnings.

While the company's five consecutive years of dividend increases is a bit shorter of a track record than I'd typically like to see, the dividend growth has been tremendous: the stock's three - year dividend growth rate is sitting at 44.2 %.

It serves customers in New Jersey and Delaware, and has increased its dividend for 42 consecutive years and still maintains a payout ratio less than two - thirds of its earnings.

Over 150 dividend stocks have increased their dividend for at least 20 consecutive years, significantly more than the 51 Dividend Arisdividend stocks have increased their dividend for at least 20 consecutive years, significantly more than the 51 Dividend Arisdividend for at least 20 consecutive years, significantly more than the 51 Dividend ArisDividend Aristocrats.

The dividend reinvestment plan (DRIP) enables you to reinvest those cash dividends rather than accepting a cheque from the company in order to increase your holdings in your portfolio.

IBM has a payout ratio of 49 %, using less than half its adjusted income to support its dividend, so there's plenty of room to support future increases.

However, I will tend to favor those which have been paying increasing dividends year after year for more than a decade.

I envy dividend growth investors who have known extended periods of time where dividends increased steadily, rather than this dividend volatility we're experiencing now.

Anyways, 11 % increase was achieved more by new investments than dividend returns and additional investments are drying up this year.

Many companies increase their dividend payments each year, meaning that each year's passive income is larger than the year before it.

With a track record of paying a dividend every year since 1890, including more than 60 consecutive years of payout increases, the company's reputation as a dependable income investment is well - earned.

Over the long term, companies that can consistently and reliably increase dividends paid to investors offer higher returns with less risk than companies that do not pay a dividend, or which do not consistently increase dividends paid to investors.

Some companies have annual dividend increases dating back more than 25 years.

Likewise, there was a four - year period between 2005 and 2009 when owners of The Hershey Company saw their investment decline on paper by more than 50 percent even though chocolate sales were increasing, on average, and dividends were growing.

The appeal increases when you consider that dividend - growth companies tend to be of higher quality and lower volatility than the broader stock market.

Stocks currently yield more than intermediate - term bonds and are expected to continue to increase their dividends.

Companies with the fundamental ability — and demonstrated willingness — to increase dividend payouts appear better positioned to offer portfolio protection than those with only high dividend yields.

Also, the recent dividend increase was not greater than the 5 year increase (Rec / 5y — my measure of dividend acceleration).

Some companies generate substantially more cash per share than they pay out, which could hint that a dividend increase is on deck for shareholders.

For those that paid a dividend in 2010, the median increase for 2011 was more than 11 %.

It is clear for all to see that The Arsenal FC is just a business that is stock holder driven (unfortunately there is no real thought for the FAN other than to keep paying the ticket prices and stop complaining) and all dealings are based on that view, to increase the profits for the share holders or to maintain the dividends paid to them.